tofacitinib and Anti-Neutrophil-Cytoplasmic-Antibody-Associated-Vasculitis

tofacitinib has been researched along with Anti-Neutrophil-Cytoplasmic-Antibody-Associated-Vasculitis* in 1 studies

Other Studies

1 other study(ies) available for tofacitinib and Anti-Neutrophil-Cytoplasmic-Antibody-Associated-Vasculitis

ArticleYear
Tofacitinib for the treatment of antineutrophil cytoplasm antibody-associated vasculitis: a pilot study.
    Annals of the rheumatic diseases, 2021, Volume: 80, Issue:12

    Topics: Adult; Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis; Blood Sedimentation; C-Reactive Protein; Churg-Strauss Syndrome; Female; Granulomatosis with Polyangiitis; Humans; Janus Kinase Inhibitors; Male; Microscopic Polyangiitis; Middle Aged; Pilot Projects; Piperidines; Pyrimidines; Treatment Outcome; Young Adult

2021
chemdatabank.com